Ongoing research within the NYU Division of Clinical Pharmacology encompasses several major areas:

• inflammation and immune-modulating drugs
• wound healing and agents designed to enhance wound healing
• hepatic cirrhosis and its therapy
• angiogenesis and atherosclerosis
• new therapies for the treatment of cancer
• pathways linking perceived stress and altered immunity

In addition, the Division has undertaken numerous research collaborations with other divisions within the Department of Medicine, including:

• Infectious Diseases (Joel Ernst, M.D.): "The role of adenosine receptors in granulomatous responses to infections"
  
  
• Rheumatology (Bruce Solitar, M.D.): "The role of adenosine receptors in the pathogenesis of flbromyalgia"
  
  
• Pulmonary/Critical Care (Jeff Gold, M.D.): "The role of adenosine receptors and genetic changes in these receptors in the development and pathophysiology of delirium tremens and other complications of alcoholism"